Multi Probiotic 4000
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80041375
- Status
- Active licence
- Licence date
- 3 April 2013
- Revision date
- 8 June 2015
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : DDS-1 | 1.15 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 1.15 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 1.15 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : LR-32 | 1.15 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Gélatine, Cellulose microcristalline, Fructooligosaccharides, Poudre d'écorce d'orme rouge
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Source of Probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
This product has come into contact with soy and dairy. Do not use if you have a soy or dairy allergy. Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80041375
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.